Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Cholangiocarcinoma”

268 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 268 results

Testing effectiveness (Phase 2)Study completedNCT04361331
What this trial is testing

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 61
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Testing effectiveness (Phase 2)Looking for participantsNCT03364530
What this trial is testing

Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectableNon-metastatic
University Hospital, Montpellier 40
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)UnknownNCT04961788
What this trial is testing

Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 30
Not applicableLooking for participantsNCT07717437
What this trial is testing

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

Who this might be right for
Liver CancerLiver Metastases
Maastricht University Medical Center 350
Not applicableStudy completedNCT02685631
What this trial is testing

Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

Who this might be right for
Localized Non-Resectable Adult Liver Carcinoma
Vanderbilt-Ingram Cancer Center 1,653
Not applicableUnknownNCT01524146
What this trial is testing

Photodynamic Therapy (PDT) Cholangiocarcinoma Registry

Who this might be right for
Unresectable CholangiocarcinomaBiliary ObstructionStent Obstruction+1 more
Weill Medical College of Cornell University 200
Early research (Phase 1)Ended earlyNCT02012231
What this trial is testing

Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.

Who this might be right for
MelanomaThyroid CancerColorectal Cancer+4 more
Fore Biotherapeutics 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Testing effectiveness (Phase 2)UnknownNCT02178280
What this trial is testing

Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma

Who this might be right for
Hilar Cholangiocarcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Early research (Phase 1)Study completedNCT03219268
What this trial is testing

MGD013 in Patients With Unresectable or Metastatic Neoplasms

Who this might be right for
Advanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more
MacroGenics 277
Testing effectiveness (Phase 2)Study completedNCT00003276
What this trial is testing

Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer

Who this might be right for
Gallbladder Cancer
Alliance for Clinical Trials in Oncology 40
Testing effectiveness (Phase 2)Ended earlyNCT02994251
What this trial is testing

A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Yale University 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685535
What this trial is testing

HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver Cancer
Shanghai Zhongshan Hospital 29
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableNot Yet RecruitingNCT07326189
What this trial is testing

Preoperative Right Hepatic Artery Embolization for Locally Advanced Bismuth IIIb and IV Perihilar Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 33
Testing effectiveness (Phase 2)Study completedNCT01862315
What this trial is testing

Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)

Who this might be right for
Intrahepatic CholangiocarcinomaPeripheral CholangiocarcinomaCholangiolar Carcinoma+1 more
Memorial Sloan Kettering Cancer Center 56
Not applicableLooking for participantsNCT06643208
What this trial is testing

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital 37
Next Page